| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.785 | 1.768 | 10.498 | 11.473 | 11.619 | 29.637 |
| Total Income - EUR | - | - | - | - | 4.869 | 1.768 | 10.498 | 11.473 | 11.619 | 29.637 |
| Total Expenses - EUR | - | - | - | - | 779 | 537 | 1.046 | 10.978 | 14.339 | 14.860 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.090 | 1.231 | 9.452 | 495 | -2.721 | 14.778 |
| Net Profit/Loss - EUR | - | - | - | - | 3.944 | 1.180 | 9.143 | 203 | -3.405 | 11.275 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gynevas Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.031 | 897 | 765 | 48.990 | 40.190 | 31.362 |
| Current Assets | - | - | - | - | 2.979 | 4.208 | 8.645 | 1.897 | 70 | 175 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 474 | 362 | 354 | 355 | 29 | 70 |
| Cash | - | - | - | - | 2.505 | 3.846 | 8.291 | 1.542 | 41 | 104 |
| Shareholders Funds | - | - | - | - | 3.986 | 5.091 | 9.227 | 7.430 | 4.002 | 11.323 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 25 | 14 | 183 | 44.140 | 37.050 | 20.983 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynevas Medical S.r.l.